• Xylocaine injection, Fresenius Kabi
  1%, 20 mL vial, 25 count (NDC 63323-0485-27)
  1%, 50 mL vial, 25 count (NDC 63323-0485-57)
  2%, 20 mL vial, 25 count (NDC 63323-0486-27)
   
  Xylocaine-MPF injection, Fresenius Kabi
  2%, 10 mL ampule, 5 count (NDC 63323-0496-97)
   
  Lidocaine Hydrochloride injection, AuroMedics
  1%, 2 mL vial, 10 count (NDC 55150-0161-02)
  1%, 5 mL vial, 10 count (NDC 55150-0162-05)
  2%, 2 mL vial, 10 count (NDC 55150-0164-02)
  2%, 5 mL vial, 10 count (NDC 55150-0165-05)
   
  Lidocaine Hydrochloride injection, Pfizer
  1%, 5 mL preservative-free glass ampule, 50 count (NDC 00409-4713-02)
  1%, 30 mL sterile-pack preservative-free vial, 25 count, NDC 00409-4270-01) - discontinued
  2%, 5 mL emergency Ansyr syringe, 10 count (NDC 00409-1323-05)
  2%, 5 mL LifeShield syringe, 10 count (NDC 00409-4903-34)

• • Amphastar had lidocaine 2% emergency syringes on shortage due to increase demand for the product.
  • AuroMedics introduced lidocaine injection in February 2014.
  • Fresenius Kabi had generic lidocaine presentations on shortage due to a supply interruption of raw ingredients.
  • Pfizer has lidocaine presentations on shortage due to manufacturing delays.
     
    

• Xylocaine injection, Fresenius Kabi

Estimated Resupply Dates

• • AuroMedics has 1% lidocaine 2 mL and 5 mL vials on intermittent back order and the company is releasing product as it becomes available. AuroMedics has 2% lidocaine 2 mL and 5 mL vials on intermittent back order and the company is releasing product as it becomes available.
  • Fresenius Kabi has 1% Xylocaine 20 mL and 50 mL vials on back order and the company estimates a release date of late-July 2017 for the 20 mL vials and mid-July 2017 for the 50 mL vials. The 2% Xylocaine 20 mL vials are on back order and the company estimates a release date of mid-July 2017. The 2% Xylocaine-MPF 10 mL ampules are on intermittent back order and the company is releasing product as it becomes available.
  • Pfizer has 1% lidocaine 5 mL preservative-free ampules on back order and the company estimates a release date of early-July 2017. The 2% lidocaine 5 mL Ansyr syringes and 5 mL LifeShield syringes are on back order and the company estimates a release date of early-July 2017 for the Ansyr syringes and mid-August 2017 for the LifeShield syringes.